Crossmark

Impact of the 13-valent conjugate pneumococcal vaccine on the incidence of invasive pneumococcal disease in Catalonia: Retrospective study, 2014–2015 vs. 2017–2018

Crossref DOI link: https://doi.org/10.1016/j.vacune.2022.01.001

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Broner, S.

Izquierdo, C.

Nogueras, M.M.

Hernández, S.

Muñoz-Almagro, C.

Pallarés, R.

Jané, M.

Ciruela, P.
License Information

Text and Data Mining valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Impact of the 13-valent conjugate pneumococcal vaccine on the incidence of invasive pneumococcal disease in Catalonia: Retrospective study, 2014–2015 vs. 2017–2018

Journal Title: Vacunas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacune.2022.01.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.vacun.2021.05.005

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below